The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
Open accessAbstract
Objectives To develop recommendations for monitoring patients with systemic lupus erythematosus (SLE) in clinical practice and observational studies and to develop a standardised core set of variables to monitor SLE. Methods We followed the European League Against Rheumatism (EULAR) standardised procedures for guideline development. The following techniques were applied: nominal groups, Delphi surveys for prioritisation, small group discussion, systematic literature review and two Delphi rounds to obtain agreement. The panel included rheumatologists, internists, dermatologists, a nephrologist and an expert related to national research agencies. The level of evidence and grading of recommendations were determined according to the Levels of Evidence and Grades of Recommendations of the Oxford Centre for Evidence-Based Medicine. Results A total of 10 recommendations have been developed, covering the following aspects: patient assessment, cardiovascular risk factors, other risk factors (osteoporosis, cancer), infection risk (screening, vaccination, monitoring), frequency of assessments, laboratory tests, mucocutaneous involvement, kidney monitoring, neuropsychological manifestations and ophthalmology assessment. A ‘core set’ of minimal variables for the assessment and monitoring of patients with SLE in clinical practice was developed that included some of the recommendations. In addition to the recommendations, indications for specific organ assessments that were viewed as part of good clinical practice were discussed and included in the flow chart. Conclusions A set of recommendations for monitoring patients with SLE in routine clinical practice has been developed. The use of a standardised core set to monitor patients with SLE should facilitate clinical practice, as well as the quality control of care for patients with SLE, and the collection and comparison of data in observational studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–243 of 243
Bone mineral density in premenopausal women with systemic lupus erythematosus.
Uaratanawong, S., Deesomchoke, U., Lertmaharit, S., et al. (2003) · PubMed · Cited by 53
Lung cancer in systemic lupus erythematosus
Bin, J., Bernatsky, S., Gordon, C., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.01.007 · Cited by 53
Self-citationQamar, T., Levy, R. A., Sammaritano, L. R., Gharavi, A. E., & Lockshin, M. D. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330406 · Cited by 53
Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients
Formiga, F., Meco, J. F., Pintó, X., Jacob, J., Moga, I., & Pujol, R. (2001) · Lupus · doi:10.1191/096120301669070811 · Cited by 52
Alarcón, G. S., Cianfrini, L. R., Bradley, L. A., Sanchez, M. L., Brooks, K., Friedman, A., Baethge, B. A., Fessler, B. J., Bastian, H. M., Roseman, J. M., et al. (2002) · Arthritis Care & Research · doi:10.1002/art.10457 · Cited by 51
Clinically active serologically quiescent systemic lupus erythematosus.
Gladman, D. D., Hirani, N., Ibañez, D., & Urowitz, M. B. (2003) · PubMed · Cited by 50
Influenza vaccination of patients with systemic lupus erythematosus.
Mercado, U., Acosta, H., & Avendaño, L. (2004) · PubMed · Cited by 50
Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant
Nojima, J., Suehisa, E., Akita, N., Toku, M., Fushimi, R., Tada, H., Kuratsune, H., Machii, T., Kitani, T., & Amino, N. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.d01-2055.x · Cited by 47
Elkayam, O., Ablin, J. N., & Caspi, D. (2006) · Autoimmunity Reviews · doi:10.1016/j.autrev.2006.09.005 · Cited by 45
Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus
Prasad, R., Ibañez, D., Gladman, D. D., & Urowitz, M. B. (2006) · Lupus · doi:10.1191/0961203306lu2302oa · Cited by 45
Updating on the Pathogenic Mechanisms 5 of the Antiphospholipid Antibodies-Associated Pregnancy Loss
Meroni, P. L., Gerosa, M., Raschi, E., Scurati, S., Grossi, C., & Borghi, M. O. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8055-9 · Cited by 44
Gutiérrez-Adrianzén, O., Koutouzov, S., Mota, R. M. S., Medeiros, M. M. D. C., Bach, J., & Campos, H. D. H. (2006) · PubMed · Cited by 44
Jaekel, H.-P., Trabandt, A., Grobe, N., & Werle, E. (2006) · Lupus · doi:10.1191/0961203306lu2308oa · Cited by 43
Pneumococcal sepsis in patients with systemic lupus erythematosus
Naveau, C., & Houssiau, F. (2005) · Lupus · doi:10.1191/0961203305lu2242xx · Cited by 43
Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies
Mecacci, F., Bianchi, B., Pieralli, A., Mangani, B., Moretti, A., Cioni, R. M., Giorgi, L., Mello, G., & Matucci‐Cerinic, M. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken458 · Cited by 41
Chakravarty, K., BYRON, M., Webley, M., DURKIN, C. J., Al-Hillawi, A. H., Bodley, R., & WOZNIAK, J. (1991) · QJM · doi:10.1093/oxfordjournals.qjmed.a068560 · Cited by 40
Witte, T., Hartung, K., Matthias, T., Sachse, C., Fricke, M., Deicher, H., Kalden, J. R., Lakomek, H. J., Peter, H. H., & Schmidt, R. E. (1998) · Rheumatology International · doi:10.1007/s002960050059 · Cited by 38
Prophylactic use of antibiotics and immunisations in patients with SLE
Gilliland, W. R., & Tsokos, G. C. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.3.191 · Cited by 38
Ramsey‐Goldman, R., & Isenberg, D. A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11402 · Cited by 36
Tebo, A. E., Jaskowski, T. D., Hill, H. R., & Branch, D. W. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03774.x · Cited by 33
Saisoong, S., Eiam‐Ong, S., & Hanvivatvong, O. (2006) · PubMed · Cited by 33
Chloroquine-induced bull’s eye maculopathy in rheumatoid arthritis: related to disease duration?
Shinjo, S. K., Júnior, O. D. O. M., Tizziani, V. A. P., Morita, C., Kochen, J. A. L., Takahashi, W. Y., & Laurindo, I. M. M. (2007) · Clinical Rheumatology · doi:10.1007/s10067-006-0478-9 · Cited by 32
Lupus nephritis: the significance of serological tests at the time of biopsy.
Houssiau, F., D’Cruz, D. P., Vianna, J. L., & Hughes, G. R. (1991) · PubMed · Cited by 32
Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus
Bernatsky, S. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh282 · Cited by 31
Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus.
Croft, S. M., Schiffman, G., Snyder, E., et al. (1984) · PubMed · Cited by 30
Bandt, M. D., Benali, K., Guillevin, L., HACHULLA, E., Job-Deslandre, C., Fautrel, B., Fournié, G. J., Bonnet, C., Fournié, B., Le Goff, P., et al. (1999) · PubMed · Cited by 30
Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus
Tisseverasinghe, A., Lim, S., Greenwood, C. M. T., Urowitz, M. B., Gladman, D. D., & Fortin, P. R. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21929 · Cited by 29
Mosca, M., Neri, R., Giannessi, S., et al. (2001) · Lupus · doi:10.1191/096120301680416931 · Cited by 28
Self-citationCardoso, C. R. L., Signorelli, F., Papi, J. Â. D. S., & Salles, G. F. (2007) · Rheumatology International · doi:10.1007/s00296-007-0447-x · Cited by 28
Tarján, P., Sipka, S., Lakos, G., Kiss, E. V., Ujj, G., & Szegedi, G. (2006) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740500474552 · Cited by 27
López-Hoyos, M., Cabeza, R., Martínez-Taboada, V. M., Crespo, J., SanSegundo, D., Blanco, R., López-Escribano, H., Peña, M., & Rodríguez-Valverde, V (2005) · Lupus · doi:10.1191/0961203305lu2130oa · Cited by 27
Leecharoen, S., Wangkaew, S., & Louthrenoo, W. (2007) · PubMed · Cited by 25
Ignat, G. P., Rat, A., Sychra, J. J., Vo, J., Varga, J., & Teodorescu, M. (2003) · PubMed · Cited by 23
Monitoring systemic lupus erythematosus in standard clinical care
Petri, M. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.01.003 · Cited by 21
Self-citationAkimoto, T., Kobayashi, S., Tamura, N., Ohsawa, T., Kawano, T., Tanaka, M., & Hashimoto, H. (2005) · Angiology · doi:10.1177/000331970505600512 · Cited by 18
Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus
Chong, H., Chee, S., Goh, E. M. L., Chow, S. K., & Yeap, S. S. (2006) · Clinical Rheumatology · doi:10.1007/s10067-006-0258-6 · Cited by 16
THE RELATIONSHIP OF ANTICARDIOLIPIN ANTIBODIES TO DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Cooper, R., Klempt, P., STIPP, C. J., & BRINK, S. (1989) · Lara D. Veeken · doi:10.1093/rheumatology/28.5.379 · Cited by 16
Buttgereit, F., Grünewald, T., Schüler-Maué, W., Burmester, G. R., & Hiepe, F. (1997) · Clinical Rheumatology · doi:10.1007/bf02247796 · Cited by 14
The prevalence of dyslipoproteinemia in Thai patients with systemic lupus erythematosus
Siripaitoon, B., Osiri, M., Vongthavaravat, V., Akkasilpa, S., & Deesomchok, U. (2004) · Lupus · doi:10.1191/0961203304lu1084xx · Cited by 10
Prevention of cardiovascular disease in patients with rheumatic diseases
Domsic, R. T., Maksimowicz‐McKinnon, K., & Manzi, S. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.04.005 · Cited by 9
Nagy, G., Brózik, M., Tornóci, L., & Gergely, P. (2000) · PubMed · Cited by 8
Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Cited by
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Fanouriakis, A., Kostopoulou, M., Alunno, A., Aringer, M., Bajema, I., Boletis, J. N., Cervera, R., Doria, A., Gordon, C., Govoni, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215089 · Cited by 2,011
Self-citationKaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Self-citationEULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Fanouriakis, A., Kostopoulou, M., Andersen, J., Aringer, M., Arnaud, L., Bae, S.-C., Boletis, J., Bruce, I. N., Cervera, R., Doria, A., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224762 · Cited by 1,081
Self-citationBertsias, G. K., Tektonidou, M., Amoura, Z., Aringer, M., Bajema, I., Berden, J. H. M., Boletis, J., Cervera, R., Dörner, T., Doria, A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201940 · Cited by 1,007
Self-citationTreat-to-target in systemic lupus erythematosus: recommendations from an international task force
van Vollenhoven, R. F., Mosca, M., Bertsias, G., Isenberg, D., Kuhn, A., Lerstrøm, K., Aringer, M., Bootsma, H., Boumpas, D., Bruce, I. N., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205139 · Cited by 740
Self-citation
Metadata
- Authors
- Mosca, M., Tani, C., Aringer, M., Bombardieri, S., Boumpas, D., Brey, R., Cervera, R., Doria, A., Jayne, D., Khamashta, M. A., Kuhn, A., Gordon, C., Petri, M., Rekvig, O. P., Schneider, M., Sherer, Y., Shoenfeld, Y., Smolen, J. S., Talarico, R., Tincani, A., van Vollenhoven, R. F., Ward, M. M., Werth, V. P., & Carmona, L.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 69
- Issue
- 7
- Pages
- 1269-1274
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2158927265
- Cited by
- 377
- References
- 243
- FWCI
- 12.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.